Health Department

Posted on: May 17, 2017

5/17/17- Potential for Falsely Low Blood Lead Test Results from LeadCare® Analyzers

The FDA has issued a safety communication warning about the use of Magellan Diagnostics’ LeadCare® analyzers (LeadCare, LeadCare II, LeadCare Ultra and LeadCare Plus) with venous blood samples because they might result in falsely low test results

Read on...
Facebook Twitter Google Plus Email